The Australian Securities and Investments Commission (ASIC) is scrutinizing the collapsed initial public offering (IPO) of neocloud company Firmus, focusing on whether the investment banks and stockbrokers involved acted appropriately in representing investor demand. The aborted listing, which aimed to achieve a market capitalization approaching $44 billion on the Australian Securities Exchange (ASX), has raised questions about the accuracy and transparency of demand indications during the bookbuild process last month.

ASIC is investigating if the joint lead managers—JPMorgan, Bank of America, Morgans, and Morgan Stanley—had a reasonable basis for their statements regarding investor interest and whether they adequately communicated material changes as the IPO unfolded. Central to the inquiry is whether the banks were merely reporting the central spreadsheet of indicative, non-binding orders or if some parties may have exaggerated demand to stimulate market enthusiasm. Another concern relates to periods of silence from deal participants, leaving investors uncertain about the status of the offering.

Sources linked to one lead manager, speaking anonymously, indicated that during the bookbuild, indications of interest peaked at around $11.2 billion, though these did not convert into binding orders. Other accounts suggest that just before the bookbuild began in early October, indications exceeded the $5 billion in available stock, with Morgans senior adviser Hugh Robertson reportedly telling clients demand was "enormous," surpassing $7.5 billion. The official position from the deal team maintained that approximately half of the $7.8 billion worth of Firmus shares (US$5.5 billion) on offer were to be allocated to a small group of strategic and institutional shareholders, and that investor interest exceeded the offer size.

Complicating the IPO’s trajectory was the public announcement that Firmus and CDC Data Centres had ceased collaborating on the Project Southgate development, despite the split occurring earlier in 2026. This news, coupled with a 9 percent stock decline in Nasdaq-listed neocloud CoreWeave during the week of the bookbuild, contributed to investor apprehension. When major investors, including San Francisco-based hedge fund Coatue Management, reduced or withdrew their bids, the momentum behind the IPO faltered.

Additionally, questions have emerged regarding potential conflicts of interest involving Morgans. The firm’s equity capital markets team was advising on the IPO pricing while its wealth advisers marketed shares to new investors at substantially higher valuations. Morgans’ staff and clients reportedly held around $500 million in Firmus shares, a significant exposure given the firm stood to earn considerable fees from the offering. While the participation might be interpreted as a sign of confidence, the scale of internal investment raises governance and compliance concerns, as large staff holdings in companies they advise on are generally avoided in investment banking to prevent conflicts.

Morgans responded by emphasizing that client and staff shareholdings are managed through their nominee company, with staff holdings constituting a small portion. The firm highlighted that all staff involvement in capitalraisings adheres to internal policies, governance procedures, and risk committee approval. Morgans deferred further comment on regulatory matters to ASIC.

Among the joint lead managers, views on Firmus’s valuation varied. Morgan Stanley set an enterprise value range between US$65 billion and US$90 billion, including debt, while Bank of America estimated US$58 billion to US$70.4 billion. JPMorgan took a more cautious stance, refraining from providing explicit valuations and noting that while Firmus exhibits strong growth prospects and strategic value, returns hinge heavily on execution and funding.

The failure of the Firmus IPO adds uncertainty to the Australian IPO market, which has recorded approximately US$2 billion in offerings this year, consistent with 2025 levels. Market participants continue to monitor ASIC’s investigations closely as bankers weigh the implications for the pipeline of upcoming ASX listings into 2027.